Pulmonary Function, Muscle Strength, Time to Extubation and Quality of Recovery in the Post Anesthesia Care Unit After Reversal of Neuromuscular Blockade With Neostigmine or Sugammadex.
Phase of Trial: Phase IV
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 06 Nov 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
- 06 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Nov 2017.
- 31 May 2017 Planned number of patients changed from 60 to 80.